Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 9Carcinoma, Non-Small-Cell Lung 7Colorectal Neoplasms 6Breast Neoplasms 6Prostatic Neoplasms 5Papillomavirus Infections 5Ovarian Neoplasms 4Neoplastic Cells, Circulating 4Uterine Cervical Neoplasms 3Uterine Cervical Dysplasia 3Lung Neoplasms 3Melanoma 2Lymphoma, Follicular 2Leukemia, Myeloid, Acute 2Hematologic Neoplasms 2Carcinoma, Hepatocellular 2Thymic aplasia 1Stomach Neoplasms 1Solid Tumor, Adult 1Small Cell Lung Carcinoma 1Respiratory Distress Syndrome 1Recurrence 1Rectal Neoplasms 1Radiation Injuries 1Pulmonary Disease, Chronic Obstructive 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Precancerous Conditions 1Pancreatic Neoplasms 1Osteosarcoma 1Opioid-Related Disorders 1

Interventions

Tacrolimus 1Phlebotomy 1Cyclosporins 1Cyclosporine 1Blood Specimen Collection 1Antilymphocyte Serum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Immunologic Deficiency Syndromes × Blood Specimen Collection × Clear all
NCT02274662 2025-01-16

Expanded Access Protocol Thymus Transplantation

Sumitomo Pharma Switzerland GmbH

Phase 4 Completed
11 enrolled 10 charts

Thymic aplasia, Immunologic Deficiency Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡